Navigation Links
Media reports ignore that Global Fund resources deliver tremendous results in the fight against AIDS
Date:2/7/2011

February 7, 2011 Geneva, Switzerland. Following the publication of several media reports which seriously distort the extent of fraud discovered in grants financed by the Global Fund to Fight AIDS, TB and Malaria, the International AIDS Society (IAS) urges all donors and governments to continue their funding.

The Global Fund is a unique and innovative financing instrument which attracts, manages and disburses resources to prevent and treat HIV/AIDS, tuberculosis and malaria. The fund is the most effective mechanism through which to disburse large amounts of resources rapidly and is credited with saving millions of lives. It is recognized as such by the international community. When the Global Fund was first created in 2002, only 40,000 people living with HIV in low and middle-income countries were receiving life saving anti-retroviral drugs. By December 2009, Global Fund-supported programmes were providing antiretroviral therapy to 2.5 million individuals in 104 low and middle-income countries, and the Global Fund Board had approved proposals totaling USD 19.2 billion and disbursed over USD 10 billion for HIV, TB and malaria control efforts to over 140 countries.

A distinguishing feature of the Global Fund is its strict and transparent auditing system, and its openness when it uncovers corruption. "Last week's reports on this subject contained no real news, and only referred to the Global Fund's own published audits which openly acknowledged that sums of money had been misappropriated," commented Julio Montaner, IAS Past President. "It would be a bitter irony if the Global Fund loses funding because of these reports, only for the same resources to be directed towards other multinational aids agencies who face the same challenges when it comes to fraud, but who may not be as transparent in their reporting. "

"All fraud is unacceptable and international financing mechanisms such as the Global Fund must work rigorously to ensure that
'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
41-227-100-822
International AIDS Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study finds problems with reviewing medical images from portable media
2. Ben-Gurion U. researchers: High resistance rates among acute otitis media pathogens in children
3. Study Finds Teens Late Night Media Use Comes at a Price
4. Violent Media Can Desensitize the Minds of Young Males
5. Interactive media improved patients’ understanding of cancer surgery by more than a third
6. Mayo Clinic Center for Social Media launches global Social Media Health Network
7. Studies identify complications in women undergoing mastectomy and immediate breast reconstruction
8. Disease transmission model says media coverage cuts infection rate and pandemic extent
9. Study finds more Americans bypassing their personal physician when immediate treatment required
10. U.S. Pediatricians Decry Medias Portrayal of Sex
11. Media detective tool empowers children to skirt alcohol and tobacco marketing messages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Randy Dotinga HealthDay Reporter ... parasite that causes malaria is growing increasingly resistant to the ... reports. But several new drugs are in development, and at ... against this global killer. "Although there has been considerable ... against malaria is far from won, and there is still ...
(Date:7/31/2014)... 31, 2014 ReputationChief.Com, a well-recognized ... online reputation management service named ‘Remove Pissed Consumer’. ... organizations get rid of Pissed Consumer Complaints. , ... extensive research. ReputationChief.Com management assigned the responsibility to ... who are struggling in their social or professional ...
(Date:7/31/2014)... July 31, 2014 -- A new study by researchers ... a peptide called caerulein can convert existing cells in ... diabetes-insulin-producing beta cells. The study, published online July 31 ... new approach to treating the estimated 3 million people ... with type 1 diabetes. , "We have found a ...
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... healthcare providers, strives in maintaining the highest standards ... That is why Healthpointe is offering Occupational ... surrounding employers, employees and patients. They also accept ... carriers. , Healthpointe’s Occupational Medicine services include, but ...
(Date:7/31/2014)... July 31, 2014 Dallas Fit Body ... Dallas, Texas to 3821 Ross Avenue, also in Dallas, in ... and potential members to burn fat and get in great ... move because he believes that the new space will help ... fitness results they want as well as accommodate new members ...
Breaking Medicine News(10 mins):Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3Health News:ReputationChief.Com Announces a New Online Reputation Management Service 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:Dallas Fit Body Boot Camp Moves to New Location, Announces Grand Opening Set for Saturday August 9th 2
... Mom,s touch and diet Claire-Dominique Walker, PhD, ... The quality and quantity of maternal milk and maternal-infant ... according to recent research published in Developmental Psychobiology ... early in life can shape the physiology and behaviour ...
... N.C. A multidisciplinary team of University of North Carolina ... grant to develop computer models that will allow physicians to ... airway problems. The three co-principal investigators of the ... Stephanie Davis, MD, Chief of Pediatric Pulmonology in the School ...
... , THURSDAY, Feb. 3 (HealthDay News) -- ... and their doctors better understand the condition, a new ... a personal digital assistant (PDA) device. The patients used ... and other issues three times a day for 30 ...
... ANGELES (Feb. 2, 2011) A team of scientists from ... million grant from the California Institute for Regenerative Medicine ... discoveries for specific diseases. Additionally, another team ... million grant with a medical technology company aiming to develop ...
... HealthDay Reporter , WEDNESDAY, Feb. 2 (HealthDay News) -- ... increasingly common intestinal infection Clostridium difficile , which ... recurrence far better than currently used medications. Researchers ... drug often prescribed to C. difficile patients. ...
... By Maureen Salamon HealthDay Reporter , ... have devised a process to create ready-made, easily stored ... undergoing heart surgery or kidney dialysis. Using donor ... spent more than five years engineering the "off-the-shelf" blood ...
Cached Medicine News:Health News:Brains need love, too 2Health News:UNC researchers developing computer models for pediatric airway problems 2Health News:Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies 2Health News:Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies 3Health News:New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection 2Health News:New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection 3Health News:Researchers Craft Blood Vessels for Heart, Kidney Patients 2Health News:Researchers Craft Blood Vessels for Heart, Kidney Patients 3
(Date:7/31/2014)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... 2014, on Thursday, August 7, 2014 before markets open. ... and conference call at 8:00 a.m. Eastern time (5:00 ... the call and webcast to discuss financial results and ... by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), ...
(Date:7/31/2014)... Cipla Europe NV ("Cipla") ... entered into a commercial collaboration, covering the territory ... countries, for BioQuiddity,s OneDose ReadyfusOR™ in regional anesthetic ... launch the CE Marked OneDose ReadyfusOR pre-filled with ... market late this year. The ready-to-use infusion systems ...
(Date:7/31/2014)... England , July 31, 2014 ... today announced that its subsidiary, Molecular Profiles Ltd., ... will support pharmaceutical and biotech drug developers during ... pharmaceutical development services will be supported by XenoGesis, ... to give clients a smarter route into formulation ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 3Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3
... Reportlinker.com announces that a new market research report is available in its catalogue: ... Stakeholder Opinions: Vaccines in emerging markets (Latin ... , , ... Introduction , ...
... WEST WINDSOR, N.J. , July 7 ITelagen, ... announced that it was selected by Zweena, LLC of West ... record application. ITelagen, which was selected for its expertise in EHR ... this innovative solution. , , ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 9Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 10Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 11Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 12Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 13Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 14Zweena Selects ITelagen to Host Personal Health Records Application 2Zweena Selects ITelagen to Host Personal Health Records Application 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: